Vitamin D receptor gene polymorphisms and susceptibility to urolithiasis: a meta-regression and meta-analysis.
Meta-analysis
Polymorphism
Urolithiasis
Vitamin D receptor
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
10 07 2020
10 07 2020
Historique:
received:
06
11
2019
accepted:
01
07
2020
entrez:
12
7
2020
pubmed:
12
7
2020
medline:
14
10
2021
Statut:
epublish
Résumé
The currently available data with respect to the association between vitamin D receptor (VDR) gene polymorphism and risk to urolithiasis are inconclusive and inconsistent. Hence, an exhaustive meta-analysis can solve the discrepancies and provide a hint for upcoming investigations. Herein, a meta-analysis was carried out to attain a conclusive estimate of the association between VDR gene single nucleotide polymorphisms (SNPs) and urolithiasis risk. The major databases, including ISI Web of science, Scopus, and PubMed/MEDLINE were searched systematically from until June 2020 to retrieve all relevant studies. Association between VDR gene polymorphisms, including FokI (rs2228570), TaqI (rs731236), BsmI (rs1544410), and ApaI (rs7975232), and urolithiasis risk was evaluated using pooled odds ratio (OR) and their corresponding 95% confidence interval (CI). Additionally, to seek for the potential source of heterogeneity, meta-regression analyses were exerted. Literature search led to finally finding of 33 studies evaluating the VDR gene SNPs and urolithiasis risk. It was observed that none of the four SNPs were significantly associated with urolithiasis predisposition. However, subgroup analysis confirmed higher risk of urolithiasis in East-Asian and Caucasian population with ApaI and TaqI gene polymorphism. The analyses of sensitivity acknowledged the results stability. Although this meta-analysis did not support the association of FokI, TaqI, BsmI, and ApaI in the overall polled analysis, it suggests that ApaI and TaqI SNPs is associated with increased risk of urolithiasis in East-Asian and Caucasians populations.
Sections du résumé
BACKGROUND
The currently available data with respect to the association between vitamin D receptor (VDR) gene polymorphism and risk to urolithiasis are inconclusive and inconsistent. Hence, an exhaustive meta-analysis can solve the discrepancies and provide a hint for upcoming investigations. Herein, a meta-analysis was carried out to attain a conclusive estimate of the association between VDR gene single nucleotide polymorphisms (SNPs) and urolithiasis risk.
METHODS
The major databases, including ISI Web of science, Scopus, and PubMed/MEDLINE were searched systematically from until June 2020 to retrieve all relevant studies. Association between VDR gene polymorphisms, including FokI (rs2228570), TaqI (rs731236), BsmI (rs1544410), and ApaI (rs7975232), and urolithiasis risk was evaluated using pooled odds ratio (OR) and their corresponding 95% confidence interval (CI). Additionally, to seek for the potential source of heterogeneity, meta-regression analyses were exerted.
RESULTS
Literature search led to finally finding of 33 studies evaluating the VDR gene SNPs and urolithiasis risk. It was observed that none of the four SNPs were significantly associated with urolithiasis predisposition. However, subgroup analysis confirmed higher risk of urolithiasis in East-Asian and Caucasian population with ApaI and TaqI gene polymorphism. The analyses of sensitivity acknowledged the results stability.
CONCLUSION
Although this meta-analysis did not support the association of FokI, TaqI, BsmI, and ApaI in the overall polled analysis, it suggests that ApaI and TaqI SNPs is associated with increased risk of urolithiasis in East-Asian and Caucasians populations.
Identifiants
pubmed: 32650740
doi: 10.1186/s12882-020-01919-1
pii: 10.1186/s12882-020-01919-1
pmc: PMC7350604
doi:
Substances chimiques
Receptors, Calcitriol
0
VDR protein, human
0
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
263Références
Urol J. 2016 Mar 05;13(1):2509-18
pubmed: 26945655
Urol Res. 2012 Feb;40(1):35-40
pubmed: 21814771
Gene. 2019 Aug 30;711:143936
pubmed: 31212049
Eur Urol. 2003 Jul;44(1):150-4
pubmed: 12814692
PLoS One. 2019 Feb 11;14(2):e0212183
pubmed: 30742686
J Natl Cancer Inst. 1959 Apr;22(4):719-48
pubmed: 13655060
Urolithiasis. 2019 Apr;47(2):149-154
pubmed: 29549381
J Endourol. 2005 Jan-Feb;19(1):111-5
pubmed: 15735395
Ann Allergy Asthma Immunol. 2020 Jan;124(1):57-69
pubmed: 31654764
PLoS One. 2015 Jun 24;10(6):e0130790
pubmed: 26107257
BMC Med Genet. 2013 Oct 06;14:104
pubmed: 24093218
Nephrol Dial Transplant. 2004 Sep;19(9):2259-65
pubmed: 15213319
J Investig Med. 2011 Aug;59(6):938-46
pubmed: 21613960
PLoS Genet. 2012;8(3):e1002541
pubmed: 22396660
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Kidney Int. 2011 Sep;80(6):587-93
pubmed: 20962745
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
Urol Int. 2002;68(3):172-7
pubmed: 11919463
FEBS Lett. 2007 May 1;581(9):1751-7
pubmed: 17418144
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):540-4
pubmed: 25166045
Urolithiasis. 2019 Jun;47(3):235-242
pubmed: 29926136
Indian J Clin Biochem. 2010 Apr;25(2):119-26
pubmed: 23105897
Hum Immunol. 2013 Dec;74(12):1659-64
pubmed: 24007655
BJU Int. 2007 Jun;99(6):1534-8
pubmed: 17419705
Urol Res. 2012 Aug;40(4):277-84
pubmed: 22116536
Mult Scler. 2009 May;15(5):563-70
pubmed: 19383647
BMC Med Genet. 2011 Aug 03;12:103
pubmed: 21810276
Urolithiasis. 2018 Aug;46(4):349-356
pubmed: 29085969
Scanning Microsc. 1996;10(2):471-84; discussion 484-6
pubmed: 9813625
Urology. 2010 Apr;75(4):923-7
pubmed: 20018354
Am J Epidemiol. 2009 Feb 15;169(4):505-14
pubmed: 19126586
J Intern Med. 2003 Feb;253(2):194-200
pubmed: 12542560
Turk J Pediatr. 2017;59(4):404-409
pubmed: 29624220
J Hum Genet. 2002;47(8):413-8
pubmed: 12181642
J Recept Signal Transduct Res. 2015 Feb;35(1):58-62
pubmed: 24898467
Urol Int. 2010;85(1):100-5
pubmed: 20339297
Urolithiasis. 2016 Apr;44(2):109-15
pubmed: 26275878
J Urol. 2002 May;167(5):2188-91
pubmed: 11956476
Ren Fail. 2016;38(4):545-51
pubmed: 26908058
BMC Med Genet. 2014 May 02;15:50
pubmed: 24886237
Urolithiasis. 2014 Feb;42(1):45-52
pubmed: 24190699
J Spinal Cord Med. 2010;33(3):202-13
pubmed: 20737793
Rev Urol. 2007 Winter;9(1):17-27
pubmed: 17396168
Pediatr Nephrol. 2005 Jun;20(6):773-6
pubmed: 15856322
Urol Res. 2004 Jun;32(3):236-40
pubmed: 15205858
Urol Res. 2006 Feb;34(1):47-52
pubmed: 16397775
Zhongguo Dang Dai Er Ke Za Zhi. 2012 Dec;14(12):956-9
pubmed: 23234786
J Clin Invest. 2003 Mar;111(5):607-16
pubmed: 12618515
PLoS One. 2013 Jun 21;8(6):e67663
pubmed: 23805323
Ann Hum Genet. 2009 Mar;73(2):176-83
pubmed: 19133942
J Urol. 1996 Feb;155(2):432-40
pubmed: 8558629
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Indian J Clin Biochem. 2008 Apr;23(2):106-16
pubmed: 23105735
BMC Neurol. 2019 Dec 26;19(1):339
pubmed: 31878897
Iran J Allergy Asthma Immunol. 2009 Sep;8(3):141-7
pubmed: 20124605
J Endourol. 1999 May;13(4):313-6
pubmed: 10405913
Environ Mol Mutagen. 2004;43(2):121-7
pubmed: 14991752
Hum Mol Genet. 2004 Aug 1;13(15):1633-9
pubmed: 15175274
Urology. 2004 Oct;64(4):833-8
pubmed: 15491743
Ir J Med Sci. 2019 Feb;188(1):169-172
pubmed: 29748892
J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S457-63
pubmed: 10541283
World J Urol. 2012 Feb;30(1):77-83
pubmed: 21720861
J Urol. 2005 Oct;174(4 Pt 1):1472-6
pubmed: 16145474
Mol Urol. 2001 Spring;5(1):7-10
pubmed: 11689145
Nutrients. 2018 Mar 17;10(3):
pubmed: 29562593
J Nutr Sci. 2019 Feb 28;8:e8
pubmed: 30854201
Cancer Causes Control. 2007 Nov;18(9):989-99
pubmed: 17653830
Urol Int. 2011;86(3):249-55
pubmed: 21325790
Nat Genet. 2009 Aug;41(8):926-30
pubmed: 19561606
Int J Urol. 2007 Dec;14(12):1060-2
pubmed: 18036039
Am J Kidney Dis. 2000 Sep;36(3):615-25
pubmed: 10977795
BJU Int. 2001 Feb;87(3):168-71
pubmed: 11167636
Am J Clin Nutr. 1994 Oct;60(4):619-30
pubmed: 8092101
Miner Electrolyte Metab. 1999 May-Jun;25(3):185-90
pubmed: 10436404
J Evid Based Med. 2015 Feb;8(1):2-10
pubmed: 25594108
Urolithiasis. 2019 Sep 12;:
pubmed: 31515573